Latest Biotech News

An unprecedented multi-ancestry meta-analysis has identified novel genetic susceptibility loci associated with keloid formation, a complex fibroproliferative skin disorder. By integrating diverse...

Researchers have engineered fluorescent dual agonist probes targeting GLP1R and GIPR receptors, enabling unprecedented visualization of incretin hormone action within pancreatic and neural...

Australian pharma giant CSL announced a comprehensive restructuring plan involving the separation of its vaccine subsidiary Seqirus as an independent publicly listed company by mid-2026, alongside...

The FDA has approved Rocket Pharmaceuticals to resume its pivotal Phase 2 gene therapy trial for Danon disease, a rare genetic disorder affecting multiple organs including the heart. The trial had...

Viking Therapeutics reported Phase 2 data for its oral obesity drug VK-2735 showing statistically significant weight loss of up to 12.2% after 13 weeks at the highest dose. However, the study...

Australian biopharma CSL announced a strategic overhaul involving the separation of its influenza vaccine business, Seqirus, into a standalone company projected to be completed by June next year....

Emerging companies and academic groups are advancing epigenomic analysis and single-cell technologies to enhance precision medicine and biological insights. Epigenica, a Swedish startup, is...

Research continues to illuminate mechanisms and treatments for neurodegenerative diseases. Eli Lilly plans to replace Anne White, head of its neuroscience division, after her retirement in...

Industry leaders are leveraging AI and data analytics to transform biologics development and drug discovery. Sanofi's iCMC digital transformation program employs data, machine learning, and...

Recent studies cover therapeutic and diagnostic advances in oncology. Natera presented improved survival data in Signatera-positive bladder cancer patients receiving Tecentriq, progressing towards...

Groundbreaking technologies are shaping neonatal and pediatric medicine. Virtual reality simulation for neonatal resuscitation training has been piloted, combining immersion with life-saving...

Researchers are unveiling new biotechnologies aimed at environmental sustainability and agricultural innovation. University of Missouri-led studies reveal poplar trees dynamically regulate wood...

At the Bioprocessing Summit in Boston, Sanofi’s digital transformation lead, Cenk Undey, outlined the integration of AI, data analytics, and automation to revolutionize biologics manufacturing....

Angle has entered a research collaboration with Myriad Genetics to co-develop liquid biopsy assays leveraging Angle’s Parsortix platform for circulating tumor cell (CTC) capture. The partnership...

Consumer health company Molecular You completed a $5 million Series A round led by Voloridge Health to enhance its blood test platform analyzing over 250 biomarkers for 26 health conditions and...

UC San Diego researchers have pioneered Graphene-Mediated Optical Stimulation (GraMOS), a novel technique using light to activate and mature neurons grown on graphene-coated substrates. The method...

Former FDA Commissioner Stephen Hahn has been named CEO of Nucleus RadioPharma, a contract developer and manufacturer specializing in radiopharmaceuticals and radioligand therapies. These...

Sarepta Therapeutics announced significant progress on its SRP-1003 siRNA candidate for Myotonic Dystrophy type 1 (DM1), activating a $100 million milestone payment to partner Arrowhead...

Viking Therapeutics' oral GLP-1/GIP agonist VK-2735 demonstrated up to 12.2% weight loss in a phase 2 trial after 13 weeks. However, high gastrointestinal adverse events led to a 38%...

Australian pharmaceutical company CSL announced a strategic overhaul including a workforce reduction of up to 15% and the spin-off of its influenza vaccine business, Seqirus, into an independent...